Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to -$291.3 million.

  • CorMedix's Cash from Investing Activities fell 470850.1% to -$291.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$312.0 million, marking a year-over-year decrease of 465648.45%. This contributed to the annual value of $21.2 million for FY2024, which is 22443.5% up from last year.
  • Per CorMedix's latest filing, its Cash from Investing Activities stood at -$291.3 million for Q3 2025, which was down 470850.1% from -$20.2 million recorded in Q2 2025.
  • CorMedix's 5-year Cash from Investing Activities high stood at $8.9 million for Q1 2024, and its period low was -$291.3 million during Q3 2025.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$256218.0 (2021), whereas its average is -$19.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 38541.16% in 2022, then plummeted by 470850.1% in 2025.
  • CorMedix's Cash from Investing Activities (Quarter) stood at -$7.1 million in 2021, then skyrocketed by 99.97% to -$1861.0 in 2022, then crashed by 789088.88% to -$14.7 million in 2023, then skyrocketed by 97.93% to -$304161.0 in 2024, then crashed by 95678.37% to -$291.3 million in 2025.
  • Its Cash from Investing Activities was -$291.3 million in Q3 2025, compared to -$20.2 million in Q2 2025 and -$194820.0 in Q1 2025.